Abstract
Aspirin, diclofenac, diflunisal, ibuprofen and indomethacin were given orally or intravenously to fasted or fed rats. The resulting gastric and intestinal damage was assessed using standard methods. The same drugs were administered to rats with biliary fitulas, and the fraction of drug excreted in bile was quantified using HPLC methods. We found that gastric damage occurred only in the fasted animals and was found to be dose-dependent and related to the amount (r=0.871) and solubility (r=0.909) of the individual drug. As far as acute gastric toxicity is concerned, neither the potency of a drug as an inhibitor of cyclo-oxygenase nor the fraction of unchanged or conjugated agent excreted in bile appeared to be relevant. Secondly, ulcerations of the small intestine occurred in fed animals only. The degree of damage was related to the amount of unchanged or conjugated drug excreted in bile and cyclo-oxygenase inhibitory potency (r=0.873). The administered dose (within the range investigated) and drug solubility appeared not to contribute to intestinal toxicity. It is concluded that, in the rat, acute gastric and intestinal toxicity of non-steroidal anti-inflammatory drugs are due to different mechanisms. Whereas gastric toxicity is strongly influenced by the amount of drug dissolved under the pH conditions in the stomach, intestinal toxicity appears to depend on biliary excretion and enterohepatic circulation of a drug as well as on its potency as an inhibitor of prostaglandin synthesis.
Similar content being viewed by others
References
Amick EN, Mason WD (1979) Determination of aspirin, salicylic acid, salicyluric acid, and gentisic acid in human plasma and urine by high pressure liquid chromatography. Anal Lett 12(B6): 629–640
Beermann B (1985) Peptic ulcers induced by piroxicam. Br Med J 290: 789
Bollmann JL (1948) A cage which limits the activity of rats. J Lab Clin Md 33: 1348
Brodie DA, Hooke KF (1971) Effects of route of administration on the production of gastric hemorrhage in the rat by aspirin and sodium salicylate. Am J Dig Dis 16: 985–989
Brune K (1987) Pharmakologische Kenndaten als Basis einer Differentialtherapie mit nicht-steroidalen Anti-phlogistika. Z Rheumatol 46: 13–18
Brune K, Lanz R (1985) Pharmacokinetics of non-steroidal antiinflammatory drugs. In: Bonta IL, Bray MA, Parnham MJ (eds) Handbook of inflammation, Vol 5. Elsevier, Amsterdam, pp 413–449
Brune K, Glatt M, Kaelin H, Peskar BA (1978) Pharmacological control of prostaglandin and thromboxane release from macrophages. Nature 274: 261–263
Brune K, Rainsford KD, Wagner K, Peskar BA (1981) Inhibition by anti-inflammatory drugs of prostaglandin production in cultured macrophages. Factors influencing the apparent drug effects. Naunyn-Schmiedeberg's Arch Pharmacol 315: 269–276
Brune K, Dietzel K, Nuernberg B, Schneider HT (1987 a) Recent insight into the mechanism of gastrointestinal tract ulceration. Scand J Rheumatol Suppl 65: 135–140
Brune K, Nuernberg B, Szelenyi I, Vergin H (1987 b) The enterohepatic circulation of some anti-inflammatory drugs may cause intestinal ulcerations. In: Rainsford KD, Velo GP (eds) Side-effects of anti-inflammatory drugs, Part two: Studies in major organ systems. MTP Press, Lancaster, pp 29–37
Collier DSJ, Pain JA (1985) Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 26: 359–363
Davenport HW (1967) Salicylate damage to the gastric mucosal barrier. N Engl J Med 276: 1307–1312
Duggan DE, Hooke KF, Noll RM, Kwan KC (1975) Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochem Pharmacol 25: 1749–1754
Fenner H, Mixich G (1973) NMR studies of the molecular structure of azapropazone and interpretation of its pharmacokinetics and biotransformation. Arzneim Forsch (Drug Res) 23(5): 667–669
Fini A, Laus M, Orienti I, Zecchi V (1986) Dissolution and partition thermodynamic functions of some anti-inflammatory drugs. J Pharm Sci 75(1): 23–25
Geisslinger G, Dietzel K, Loew D, Schuster O, Rau G, Lachmann G, Brune K (1989) High-performance liquid Chromatographic determination of ibuprofen, its metabolites and enantiomers in biological fluids. J Chromatogr 491: 139–149
Godbillon J, Gauron S, Metayer JP (1985) High-performance liquid Chromatographic determination of diclofenac and its monohydroxylated metabolites in biological fluids. J Chromatogr 338: 151–159
Herzfeldt CD, Kuemmel R (1983) Dissociation constants, solubilities and dissolution rates of some selected non-steroidal anti-inflammatories. Drug Dev Ind Pharm 9(5): 767–793
Hoftiezer JW, Burks M, Silvoso GR, Ivey KJ (1980) Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man. Lancet ii: 609–612
Kwan KC, Breault GO, Umbenhauer ER, McMahon FG, Duggan DE (1976) Kinetics of indometacin absorption, elimination and enterohepatic circulation in man. J Pharmacol Biopharm 4: 255–280
Langman MJS, Morgan L, Worrall A (1985) Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J 290: 347–349
Lanza FL (1984) Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other non-steroidal anti-inflammatory agents. Am J Med Jul 13: 19–24
Laufen H, Leitold M, Riedel KD (1984) The effect of activated charcoal on the gastrointestinal absorption and reabsorption of piroxicam in dog and man. In: Abstracts, 2nd European Congress of Biopharmaceutics and Pharmacokinetics, Salamanca, p 356
Levy M, Miller DR, Kaufman DW, Siskind V, Schwingl P, Rosenberg L, Strom B, Shapiro S (1988) Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other non-narcotic analgesics. Arch Int Med 148: 281–285
Martin BK (1963) Accumulation of drug anions in gastric mucosal cells. Nature 198: 896–897
McCormack K, Brune K (1987) Classical absorption theory and the development of gastric mucosal damage associated with the nonsteroidal anti-inflammatory drugs. Arch Toxicol 60: 261–269
Menasse R, Hedwall PR, Kraitz J, Pericin C, Riesterer L, Sallmann A, Ziel R, Jaques R (1978) Pharmacological properties of diclofenac sodium and its metabolites. Scand J Rheumatol Suppl 22: 5–16
Moeller N, Dietzel K, Schneider HT, Brune K (1989) Novel 5-aminosalicylic acid NSAID conjugates: synthesis, pharmacological and toxicological properties. Eur J Med Chem 24: 463–469
Nielsen-Kudsk F (1980) HPLC-determination of some antiinflammatory, weak analgesics and uricosuric drugs in human blood plasma and its application to pharmacokinetics. Acta Pharmacol Toxicol 47: 267–273
Nuernberg B, Brune K (1986) Analyse der biliären Elimination eines nicht-steroidalen Antirheumatikums (Diflunisal) bei Mensch und Hund. Akt Rheumatol 11: 116 -120
Paulus HE (1985) FDA Arthritis Advisory Committee Meeting: Postmarketing surveillance of non-steroidal anti-inflammatory drugs. Arth Rheum 28(10): 1168–1169
Paumgartner G, Horak W, Probst P, Grabner G (1971) Effect of phenobarbital on bile flow and bile salt excretion in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 270: 98–101
Peskar BA, Steffens C, Peskar BM (1979) Radioimmunoassay of 6-ketoprostaglandin F1α in biological material. In: Albertini A, Da Prada M, Peskar BA (eds) Radioimmunoassay of drugs and hormones in cardiovascular medicine. Elsevier, Amsterdam, pp 239–250
Pfeiffer CJ, Lewandowski LG (1971) Comparison of gastric toxicity of acetylsalicylic acid with route of administration in the rat. Arch Int Pharmacodyn 190: 5–13
Rainsford KD (1982) An analysis of the gastro-intestinal side-effects of non-steroidal anti-inflammatory drugs, with particular reference to comparative studies in man and laboratory species. Rheumatol Int 2: 1–10
Rainsford KD, Brune K (1978) Selective cytotoxic actions of aspirin on parietal cells: a principal factor in the early stages of aspirin-induced gastric damage. Arch Toxicol 40(2): 143–150
Rossi AC, Hsu JP, Faich GA (1987) Ulcerogenicity of piroxicam: an analysis of spontaneously reported data. Br Med J 294: 147
Schneider HT, Nuernberg B, Dietzel K, Brune K (1990) Biliary elimination of non-steroidal anti-inflammatory drugs in patients. Br J Clin Pharmacol 29: 127–131
Shen TY (1981) Toward more selective anti-arthritic therapy. J Med Chem 24(1): 1–5
Shen TY, Winter CA (1977) Chemical and biological studies on indomethacin, sulindac and their analogs. Adv Drug Res 12: 89–245
Smith PC, Benet LZ (1984) High-performance liquid Chromatographic method for the determination of indomethacin and its two primary metabolites in urine. J Chromatogr 306: 315–321
Somerville K, Faulkner G, Langman M (1986) Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet i: 462–464
St John DJB (1975) Gastric mucosal damage by aspirin. CRC Crit Rev Toxicol June 1975: 317–344
Walt R, Katschinski B, Logan R, Ashley J, Langman M (1986) Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet i: 489–492
Whittle BJR (1981) Arachidonic acid metabolites and the gastrointestinal toxicity of anti-inflammatory agents. Prostaglandins Suppl 21: 113–118
Yesair DW, Callahan M, Remington L, Kensler CJ (1970) Role of the entero-hepatic cycle of indomethacin on its metabolism, distribution in tissues and its excretion by rats, dogs and monkeys. Biochem Pharmacol 19: 1579–1590
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Beck, W.S., Schneider, H.T., Dietzel, K. et al. Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats. Arch Toxicol 64, 210–217 (1990). https://doi.org/10.1007/BF02010727
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02010727